Clinical Trial Update: A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections [NA]

View source ↗

Summary

Completed clinical trial evaluating nasal mupirocin, hexachlorophene body wash, and systemic antibiotics to prevent recurrent MRSA infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Skin Infection

Drugs mentioned

• Hexachlorophene (hexachlorophene)
• Mupirocin (Mupirocin)
• Systemic antibiotics (unspecified)

Snippet

Sponsor: Natividad Medical Center | Conditions: Methicillin Resistant Staphylococcus Aureus Skin Infections | NA | Status: COMPLETED